About

I moved from Phoenix to Seattle 5 years ago. My wife and I have a huge love of snorkeling and traveling, in part because my parents were born in Kenya and my wife’s in India. We have been to over 25 countries.

We currently live in Bellevue with Zen, our Bernedoodle puppy.

I am driven by how Zoic Capital can effect humanity and passionate about building companies that do the same; fostering disruptive innovation that leads to capital efficiency. It is important to remember that risk must be commensurate with the reward and as a result I look to truly understand the downside on innovation and how it can be mitigated. I am focused on identifying and nurturing companies from early stage to mid-success and enjoy the process of inorganic growth and study. In healthcare our mission is to identify, invest in and foster the IP process of companies that have asymmetrical optionality, where opportunities exist to change the lives of millions of people.

Market Meditations Podcast

Market Meditations is a podcast about innovators, entrepreneurs, academics and the ideas within the movements they’re building. Each featured episode is marked with introspective insight, humor, and serendipity during conversations with influencers of some of the world’s best known financial, health and life sciences sectors. Market Meditations is hosted by Chris Haydel, partner at HBAWealth and Neal Mody, Managing Director at Zoic Capital.

I moved from Phoenix to Seattle 5 years ago. My wife and I have a huge love of snorkeling and traveling, in part because my parents were born in Kenya and my wife’s in India. We have been to over 25 countries.

We currently live in Bellevue with Zen, our Bernedoodle puppy.

I am driven by how Zoic Capital can effect humanity and passionate about building companies that do the same; fostering disruptive innovation that leads to capital efficiency. It is important to remember that risk must be commensurate with the reward and as a result I look to truly understand the downside on innovation and how it can be mitigated. I am focused on identifying and nurturing companies from early stage to mid-success and enjoy the process of inorganic growth and study. In healthcare our mission is to identify, invest in and foster the IP process of companies that have asymmetrical optionality, where opportunities exist to change the lives of millions of people.